Page last updated: 2024-10-26

pentetic acid and von Hippel-Lindau Disease

pentetic acid has been researched along with von Hippel-Lindau Disease in 2 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

von Hippel-Lindau Disease: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pulcrano, M1
Camera, L1
Pagano, L1
Del Vecchio, S1
Ferone, D1
Bodei, L1
Murgia, A1
Pace, L1
Storto, G1
Paganelli, G1
Colao, A1
Salvatore, M1
Lombardi, G1
Biondi, B1
Hardjasudarma, M1
Fowler, M1

Other Studies

2 other studies available for pentetic acid and von Hippel-Lindau Disease

ArticleYear
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease.
    Journal of endocrinological investigation, 2008, Volume: 31, Issue:4

    Topics: Adult; Female; Humans; Indium Radioisotopes; Male; Octreotide; Pentetic Acid; Tomography, Emission-C

2008
Craniospinal magnetic resonance imaging enhanced with Gd-DTPA in von Hippel-Lindau disease.
    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 1991, Volume: 42, Issue:4

    Topics: Adult; Brain; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging

1991